Polio Outbreak in Pakistan
Pakistan continues to be dealing with a polio outbreak as four fresh cases have emerged, pushing the national tally to 37 this year, according to health officials on October 19, 2024. Health officials said that the regional reference laboratory for polio eradication at the National Institute of Health in Islamabad confirmed wild poliovirus type-1 (WPV1) in two children-one from each Balochistan and Khyber-Pakhtunkhwa.
In recent cases, a girl has been affected from Pishin, and two boys from Chaman and Noshki of Balochistan, and a girl from Lakki Marwat in KP. These are the first detections of the virus within Noshki and Lakki Marwat this year; isolated cases of poliovirus were previously reported within Chaman and Pishin. The province of Balochistan was the worst hit with 20 cases, Sindh had 10, Khyber Pakhtunkhwa had five, and Punjab and Islamabad had one case each.
A gigantic fight against polio has been on going in Pakistan- especially in Balochistan and southern KP-over the last two years. Immunisation campaigns have often been suspended or delayed because of local protests, insecurity, and community boycotts. Consequently, quite a number of children did not get the necessary vaccinations, making existing patches of vulnerability for the virus to flow within those pockets.
Noshki, located near Afghanistan's border, and Lakki Marwat have also recently reported some positive environmental samples that confirm the virus is present here, said a local reference laboratory official. Samples of latest cases are currently under genetic sequencing for checking spread of virus and origin.
As the threat of polio continues to grow, Pakistan has vowed to mount a nationwide campaign against it beginning from October 28. With the zeal to tackle the menace in the most effective manner, over 45 million children under the age of five will be vaccinated across the country.
Today, Afghanistan and Pakistan remain one of the few countries where polio has not yet been eradicated. The WHO said the virus remains a potential serious public health threat in areas with low vaccination coverage and weak surveillance.
The country declared itself polio-free since 2014 and has kept the disease on bay almost a decade with very robust vaccination programs; however, two cases of vaccine-derived poliovirus cases reported in recent days from Meghalaya create some amount of doubts over a possible resurgence. Experts observe that in India, despite these detections taking place, strong coverage of vaccination at 90-95% and mandatory surveillance measures keep the risk of this widespread outbreak at bay.
The experts point out, however, that such stable situation in India requires continued surveillance. "Countries like Pakistan and parts of Africa remain at a high risk because vaccination rates in those areas are much lower," Dr. Siddharth, public health expert, said. Vaccination is an indispensable act in order to avoid the spread of this incapacitating disease that manifests most importantly as a nervous system affliction leading to the paralysis of a long period.
With concerted efforts from health authorities, there is hope someday that the scourge of polio will be completely eradicated from the face of the earth and future generations will never suffer from its effects.
Credit: AI
Louisiana health officials have confirmed a rare infection caused by Naegleria fowleri, commonly called the “brain-eating amoeba,” in a resident who most likely contracted the infection after swimming in Lake Claiborne in Louisiana.
The Louisiana Department of Health confirmed the case this week, issuing a warning to people entering warm freshwater. It is the fourth documented Naegleria fowleri infection in Louisiana since 1937.
The case comes as health officials continue to warn about the seasonal risk of the amoeba, which thrives in warm freshwater, particularly during the summer months. According to CDC data, most US cases occur in July and August.
From the nasal pathway, the organism can travel along the olfactory nerves into the brain and cause primary amebic meningoencephalitis (PAM), an infection that progresses rapidly and causes inflammation and destruction of brain tissue.
Swallowing contaminated water also does not cause Naegleria infection, and the infection cannot spread from one person to another.
Also read: Fournier Gangrene: Woman Develops Rare Flesh-eating Infection After Bikini Shave, Herbal Application
Naegleria fowleri is naturally found in warm freshwater lakes, ponds and rivers, as well as some hot springs and other warm-water environments.
According to CIDRAP, the amoeba can survive at temperatures as high as about 115°F (46°C). Cases are particularly linked with freshwater exposure during periods of high temperatures.
The risk remains extremely low despite its potentially devastating outcome. The CDC recorded 180 PAM cases in the US from 1937 through 2025, with cases ranging from zero to eight per year.
The LDH said recreational water users should not assume that warm freshwater is completely risk-free. “Though the risk of infection is low, recreational water users should always assume there is a risk when they enter warm fresh water.”
The department added that people can reduce their risk by preventing water from entering your enters the nose. That can include using nose clips or keeping the nose above water when swimming in warm freshwater.
Primary amebic meningoencephalitis can initially mimic other infections. Early symptoms can include headache, fever, nausea and vomiting. As the infection progresses, patients can develop a stiff neck, confusion, problems with balance, seizures, hallucinations and loss of consciousness.
The illness progresses extremely quickly, with CDC data indicating that symptoms generally begin within 1 to 12 days after exposure. Death can occur within days after symptoms appear. As the disease is extremely rare and its early symptoms resemble other forms of meningitis, diagnosis can be challenging.
The Louisiana case follows another recent case in the state involving an 8-year-old Ruston girl, who was hospitalized after developing a Naegleria fowleri infection that health officials said may have been acquired while swimming in a North Louisiana lake.
The cases highlight the importance of taking precautions around warm freshwater during the summer, even though the overall probability of infection remains extremely small.
The CDC recommends avoiding activities in warm freshwater when possible, particularly during periods of high water temperatures. People who do enter such water can reduce exposure by using nose clips or keeping their head above water, and by avoiding stirring up sediment in shallow, warm areas.
Another important precaution concerns nasal rinsing. Naegleria can also be transmitted when contaminated tap water is used in devices such as neti pots. For nasal rinsing, the CDC recommends using distilled or sterile water, or water that has been boiled and cooled.
Credit: iStock
Amid an ongoing Salmonella outbreak that has infected hundreds of people, vulnerable groups in the UK are being advised to avoid undercooked or runny eggs.
The Food Standards Agency (FSA) issued the precautionary advice after the UK Health Security Agency (UKHSA) declared a national outbreak. The outbreak has infected 207 people across the UK, with one death and 34 hospitalisations.
Officials suspect imported eggs or food products containing imported eggs may be behind the outbreak.
However, the FSA said well-cooked eggs served in restaurants, cafes and takeaways are safe to eat.
Who Is at Risk?
The FSA advised vulnerable groups, including:
Ian Young, chief scientific adviser at the FSA, said vulnerable people eating out should ensure that eggs and egg products are thoroughly cooked.
Which Foods Should Be Avoided?
The FSA advised vulnerable people to avoid runny eggs and freshly made foods that may contain uncooked eggs, including:
Are Supermarket Eggs Safe?
Young reiterated that people can continue to buy British eggs from supermarkets. Chickens bred in the UK are vaccinated against common strains of Salmonella.
“There is no link to those eggs to this current outbreak,” he said.
He described the outbreak as “unusually large and rapidly increasing” and urged people to take precautions.
The UKHSA has launched an investigation to identify the source of the outbreak. Initial findings suggest it may be linked to eggs imported from outside the UK, although the source has not yet been definitively established.
Dr Kathleen O'Reilly, associate professor at the London School of Hygiene & Tropical Medicine, said the investigation involves identifying additional cases and examining possible common sources of infection.
Where Have Cases Been Reported?
Cases have been reported across the UK:
In England, London has reported the highest number of cases, with 47, followed by Yorkshire and the Humber with 38.
What Is Salmonella?
Salmonella is a bacterial infection that commonly causes diarrhoea and gastrointestinal illness.
Common symptoms include:
How Does Salmonella Spread?
The UKHSA stated that Salmonella Enteritidis is the most common Salmonella serovar in England and a leading cause of salmonellosis.
Like other non-typhoidal Salmonella infections, it can spread through contaminated food, including:
The bacteria can also spread through contact with contaminated environments or from person to person.
How to Reduce the Risk of Salmonella
Dr O'Reilly advised people to fully cook eggs before eating them and maintain good food hygiene.
Key precautions include:
People who develop diarrhoea or stomach cramps should rest and drink plenty of fluids. Young children, older adults and other vulnerable people who become ill should seek medical advice.
Credit: iStock
Moderna and Merck’s personalized mRNA cancer vaccine has shown statistically significant and clinically meaningful improvements. The late-stage trial showed recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) when combined with Keytruda in patients with melanoma, an aggressive form of skin cancer.
The vaccine, intismeran autogene (mRNA-4157/V940), is custom-made for each patient based on the unique genetic characteristics of their tumor. It is designed to work alongside Keytruda (pembrolizumab), an immunotherapy that helps the immune system attack cancer cells.
According to experts, the development moves personalized cancer therapy closer to a practical clinical reality.
“A tumor-specific mRNA vaccine offers a way of making the immune response more targeted by using the individual tumor’s molecular characteristics to identify the abnormal signals that the immune system should recognize,” Prof. Jyoti Bajpai, Director – Medical Precision Immuno-Oncology, Apollo Hospitals, Mumbai, told HealthandMe.
In the Phase 3 INTerpath-001 trial, the combination met its primary endpoint of recurrence-free survival (RFS) and a key secondary endpoint of distant metastasis-free survival (DMFS).
Compared with Keytruda alone, the combination of intismeran autogene and Keytruda showed statistically significant and clinically meaningful improvements in both RFS and DMFS.
The findings were reported in patients with stage IIB, IIC, III, or IV cutaneous melanoma who had undergone complete surgical removal of their cancer and had not previously received systemic therapy.
After tumor sequencing, up to ~34 patient-specific neoantigens are encoded into a single mRNA construct delivered in lipid nanoparticles.
Host cells translate the neoantigens, which are then presented on MHC, driving de novo and expanded neoantigen-specific CD8+ and CD4+ T-cell responses.
When combined with PD-1 blockade, the vaccine supplies the antigenic “signal” while the checkpoint inhibitor supplies the “permission” to attack.
“The result is a more focused, polyclonal, and potentially longer-lived anti-tumor immune response—exactly what is needed to clear residual microscopic disease after resection,” Dr. Shyam Aggarwal, Chairman, Medical Oncology, Sir Ganga Ram Hospital, told HealthandMe.
Early translational data from KEYNOTE-942 already showed durable neoantigen-specific T-cell responses, supporting the idea that the vaccine can generate immune memory that outlasts the treatment period.
“Immunotherapy releases the body’s natural brakes to attack cancer, whereas the custom vaccine acts like a precision GPS—training the immune system to recognize the unique genetic signature of that patient's specific tumour. Immunotherapy mobilizes the immune response, but the vaccine tells it exactly where to go,” Prof. Jyoti said.
“The practical implication is a shift in the adjuvant paradigm: rather than relying solely on broad immune checkpoint inhibition or chemotherapy, we can now envision adding a tumor-specific ‘instruction set’ that educates the patient’s own T-cell repertoire against the unique mutational fingerprint of their cancer,” the noted oncologist said.
He added that the manufacturing turnaround, currently ~6 weeks from biopsy to first dose, remains a logistical and cost challenge. However, the COVID-era mRNA infrastructure has shown that rapid, decentralized production of custom constructs is feasible.
India’s cancer burden has continued to rise steadily over the past five years, with the estimated number of new cancer cases increasing from 14.26 lakh in 2021 to 15.70 lakh in 2025, while annual cancer-related deaths also climbed from 7.89 lakh to an estimated 8.69 lakh during the same period, according to data placed before Parliament recently.
For India, this technology has intriguing potential, Dr Jyoti said.
While typical skin melanoma is less common here, India sees higher rates of acral and mucosal subtypes, which tend to be aggressive and diagnosed late.
“A tailored neoantigen approach could be very useful for these complex cases. However, manufacturing costs, long turnaround times for genomic sequencing, and cold-chain logistics mean translating this into routine clinical care in India may take time,” she added.
© 2024 Bennett, Coleman & Company Limited